Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Citius Oncology, Inc. (CTOR) had Debt to Capital Ratio of 0.06 for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$3.94M |
|
$-5.53M |
|
$0.79M |
|
$3.15M |
|
$9.20M |
|
$-5.25M |
|
$-0.02M |
|
$-5.27M |
|
$-5.27M |
|
$-5.53M |
|
$-5.53M |
|
$-5.53M |
|
$-5.53M |
|
$-5.25M |
|
$-4.68M |
|
87.46M |
|
87.46M |
|
$-0.06 |
|
$-0.06 |
|
| Balance Sheet Financials | |
$37.15M |
|
-- |
|
$72.83M |
|
$109.97M |
|
$44.71M |
|
$3.80M |
|
$6.85M |
|
$51.56M |
|
$58.41M |
|
$58.41M |
|
$58.41M |
|
84.80M |
|
| Cash Flow Statement Financials | |
$-7.35M |
|
$-4.40M |
|
$15.13M |
|
$3.92M |
|
$7.30M |
|
$3.37M |
|
$3.96M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.83 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.06 |
0.26 |
|
79.99% |
|
-133.17% |
|
-133.17% |
|
-- |
|
-133.61% |
|
-140.31% |
|
$-7.35M |
|
-- |
|
-- |
|
-- |
|
0.04 |
|
0.03 |
|
0.97 |
|
92.40 |
|
-9.47% |
|
-9.47% |
|
-5.03% |
|
-8.90% |
|
$0.69 |
|
$-0.08 |
|
$-0.08 |
|